NBRG

Newbridge is a blank-check shell, not an operating business. The MD&A is explicit: "We have neither engaged in any operations nor generated any operating revenues to date," and it does not expect revenue until after an initial business combination. The FY2025 income statement is pure SPAC overhead — a $221K net loss that "consisted of formation and operating expenses," with FY2024's $141K loss the only comparison point. The headline balance-sheet stress (negative $595K equity, a -9.10x liabilities/equity ratio, $5.41M liabilities) is not operating distress: $5.41M of it is the sponsor promissory note ("we have borrowed $5,414,763 under the promissory note") that funded pre-IPO costs and is due at the offering's closing. The auditor's going-concern paragraph and the $3.59M working-capital deficit at 12/31/2025 are standard pre-IPO SPAC language, largely resolved by the subsequent event that dominates the story.

That subsequent event is the whole investment case: on 2/2/2026 the company closed a $57.5M IPO (5.75M units at $10.00, over-allotment fully exercised) plus a $1.86M sponsor private placement, and deposited $57.5M into a trust with Equinity Trust Company as trustee for public shareholders. At $9.97 the stock trades just under that ~$10.00-per-share trust value, so a public holder's practical downside is bounded near the redeemable trust amount rather than by the shell's book equity. This is why the rating is hold and not avoid — the trust structure gives capital-preservation optionality that a normal negative-equity, no-revenue company would not have.